Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.8K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.9K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community Integration as a Key Role of the Rural Primary Care Physical Therapist: A Qualitative Case Study.

Physical therapy·2026
Same author

Once yearly cell-based therapy for sustained and dose tunable delivery of monoclonal antibodies.

bioRxiv : the preprint server for biology·2026
Same author

Clinical Handover as Craft, Not Checklist.

Emergency medicine Australasia : EMA·2026
Same author

Anticoagulation Practices Surrounding Emergency Department Cardioversion for Atrial Fibrillation and Flutter.

Emergency medicine Australasia : EMA·2026
Same author

Microbial communities in semi-mature oak trees are resilient to drought, nutrient limitation, and pathogen challenge.

Cell host & microbe·2026
Same author

Molecules in Wikipedia: Analysis of Their Chemical Diversity, Functional Roles, and Popularity.

Journal of chemical information and modeling·2025

Related Experiment Video

Updated: Mar 17, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization.

Sarah R Langdon1, Peter Ertl2, Nathan Brown3

  • 1In Silico Medicinal Chemistry, Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK phone/fax: +44 (0) 20 8722 4033/+44 (0) 20 8722 4205.

Molecular Informatics
|July 28, 2016
PubMed
Summary

Bioisosteric replacement and scaffold hopping are key drug design strategies. These methods improve drug properties and explore novel chemical spaces for better drug discovery.

Keywords:
BioisostereChemotypeDrug designHoppingIsostereScaffold

More Related Videos

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

783
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

8.1K

Related Experiment Videos

Last Updated: Mar 17, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

783
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

8.1K

Area of Science:

  • Medicinal Chemistry
  • Drug Design
  • Computational Chemistry

Background:

  • Bioisosteric replacement and scaffold hopping are crucial in modern drug design.
  • These techniques aim to enhance synthetic accessibility, potency, and drug-like properties.
  • They facilitate exploration of novel chemical space for new therapeutic agents.

Purpose of the Study:

  • To outline the fundamental concepts of bioisosteric replacement and scaffold hopping.
  • To discuss the importance and inherent challenges associated with these drug design methodologies.
  • To compare various techniques for identifying bioisosteric replacements and scaffold hops.

Main Methods:

  • Literature review of established and emerging techniques.
  • Comparative analysis of different bioisosteric replacement strategies.
  • Examination of scaffold hopping approaches in drug discovery.

Main Results:

  • Multiple methods exist for bioisosteric replacement and scaffold hopping, each with unique strengths and weaknesses.
  • A combination of these methods can yield diverse and complementary results for drug design projects.
  • Ongoing advancements are crucial for validating these techniques and expanding knowledge.

Conclusions:

  • Bioisosteric replacement and scaffold hopping are powerful tools for optimizing drug candidates.
  • Integrating various methods enhances the efficiency and scope of drug discovery efforts.
  • Continued research will further refine and validate these essential drug design strategies.